HP Arize 3D Orthotics for Planar Fasciitis
Primary Purpose
Plantar Fascitis
Status
Enrolling by invitation
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
HP Arize 3D-Printed Orthotics
Traditional Orthotics
Sponsored by
About this trial
This is an interventional treatment trial for Plantar Fascitis focused on measuring orthotics
Eligibility Criteria
Inclusion Criteria: At least 18 years of age Diagnosis of plantar fasciitis Access to methods of electronic communication (i.e., email) Exclusion Criteria: Previously prescribed and/or used orthotic inserts Requires additional bracing of the lower leg Diagnosis of neuropathy, acute fracture, or stress fracture Pregnant women Non-English speakers Medicare patients
Sites / Locations
- Prisma Health - Midlands
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
HP Arize 3D-Printed Orthotics
Traditional Orthotics
Arm Description
Patients will receive the HP Arize 3D-printed orthotics for treatment of plantar fasciitis.
Patients will receive traditionally fabricated orthotics for treatment of plantar fasciitis.
Outcomes
Primary Outcome Measures
Patient-reported compliance and satisfaction with orthotics.
Patient-reported compliance with traditionally fabricated or 3D-printed orthotics will be assessed at 4 weeks and 8 weeks post-initiation of orthotic wearing via a study-specific survey. This survey includes questions related to how often the patient wore their orthotics, the ease of the process, and fit and feel of the orthotics, and any experienced side effects. This survey was developed by the research team and includes subjective responses to questions; there is no score associated with this assessment.
Secondary Outcome Measures
Patient-reported secondary site pain following implementation of orthotics.
Patient-reported secondary site pain for patients wearing either traditionally fabricated or 3D-printed orthotics will be assessed at the time of consent, 4 weeks, and 8 weeks post-initiation of orthotic wearing via a study-specific survey. This survey asks patients to provide a pain score and function score for 11 locations on the body. Scores range from 0 to 100, with 0 being no pain or no limitation to physical function, and 100 being the worst pain possible or complete limitation to physical function.
Full Information
NCT ID
NCT05707013
First Posted
January 20, 2023
Last Updated
July 26, 2023
Sponsor
Prisma Health-Midlands
Collaborators
Hewlett-Packard (HP)
1. Study Identification
Unique Protocol Identification Number
NCT05707013
Brief Title
HP Arize 3D Orthotics for Planar Fasciitis
Official Title
Comparing Efficacy Between Traditionally Fabricated Foot Orthotics and the HP Arize 3D Printed Foot Orthotics
Study Type
Interventional
2. Study Status
Record Verification Date
July 2023
Overall Recruitment Status
Enrolling by invitation
Study Start Date
January 19, 2023 (Actual)
Primary Completion Date
January 30, 2024 (Anticipated)
Study Completion Date
January 30, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Prisma Health-Midlands
Collaborators
Hewlett-Packard (HP)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Currently 77% of Americans experience foot pain, of which a large portion can be attributed to plantar fasciitis.
The Arize Orthotic solution, developed in collaboration with podiatrists and leading industry experts, is a new digital solution that helps podiatrists create custom foot orthoses tailored to the patient, quickly, easily, accurately, and reliably. This pilot study will evaluate the effectiveness and clinical benefit of 3D printed foot orthotics compared to traditionally fabricated custom-made orthotics and assess compliance and patient satisfaction in patients with plantar fasciitis.
Detailed Description
Currently 77% of Americans experience foot pain, of which a large portion can be attributed to plantar fasciitis. Approximately half of the people with foot pain do not consult a doctor due to cost, convenience, or insurance reasons. To this end, HP will implement an end-to-end system to provide 3D-printed custom orthotic inserts to patients in a fast and efficient manner via their podiatrist.
The Arize Orthotic solution developed in collaboration with podiatrists and leading industry experts, is a new digital solution that helps podiatrists create custom foot orthoses tailored to the patient, quickly, easily, accurately, and reliably. The Arize Orthotic Solution leverages HP 3D Printing technology and aims to further HP's mission to create technology that makes life better for everyone, everywhere.
This pilot study will evaluate the effectiveness and clinical benefit of 3D printed foot orthotics compared to traditionally fabricated custom-made orthotics and assess compliance and patient satisfaction in patients with plantar fasciitis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Plantar Fascitis
Keywords
orthotics
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Patients will be randomized to receive traditionally fabricated orthotics or HP Arize 3D-printed orthotics for treatment of plantar fasciitis.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
HP Arize 3D-Printed Orthotics
Arm Type
Experimental
Arm Description
Patients will receive the HP Arize 3D-printed orthotics for treatment of plantar fasciitis.
Arm Title
Traditional Orthotics
Arm Type
Active Comparator
Arm Description
Patients will receive traditionally fabricated orthotics for treatment of plantar fasciitis.
Intervention Type
Device
Intervention Name(s)
HP Arize 3D-Printed Orthotics
Intervention Description
Custom 3D-printed orthotics manufactured by HP.
Intervention Type
Device
Intervention Name(s)
Traditional Orthotics
Intervention Description
Traditionally fabricated custom orthotics manufactured by a local supplier.
Primary Outcome Measure Information:
Title
Patient-reported compliance and satisfaction with orthotics.
Description
Patient-reported compliance with traditionally fabricated or 3D-printed orthotics will be assessed at 4 weeks and 8 weeks post-initiation of orthotic wearing via a study-specific survey. This survey includes questions related to how often the patient wore their orthotics, the ease of the process, and fit and feel of the orthotics, and any experienced side effects. This survey was developed by the research team and includes subjective responses to questions; there is no score associated with this assessment.
Time Frame
8 weeks
Secondary Outcome Measure Information:
Title
Patient-reported secondary site pain following implementation of orthotics.
Description
Patient-reported secondary site pain for patients wearing either traditionally fabricated or 3D-printed orthotics will be assessed at the time of consent, 4 weeks, and 8 weeks post-initiation of orthotic wearing via a study-specific survey. This survey asks patients to provide a pain score and function score for 11 locations on the body. Scores range from 0 to 100, with 0 being no pain or no limitation to physical function, and 100 being the worst pain possible or complete limitation to physical function.
Time Frame
8 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
At least 18 years of age
Diagnosis of plantar fasciitis
Access to methods of electronic communication (i.e., email)
Exclusion Criteria:
Previously prescribed and/or used orthotic inserts
Requires additional bracing of the lower leg
Diagnosis of neuropathy, acute fracture, or stress fracture
Pregnant women
Non-English speakers
Medicare patients
Facility Information:
Facility Name
Prisma Health - Midlands
City
Lexington
State/Province
South Carolina
ZIP/Postal Code
29072
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
HP Arize 3D Orthotics for Planar Fasciitis
We'll reach out to this number within 24 hrs